GRIA2 and amyotrophic lateral sclerosis: Decreased expression of GluA2 may potentially confer selective cell vulnerability by allowing Ca2+ influx into motor neurons, leading to glutamate-mediated excitotoxicity,37 a proposed central pathogenic mechanism and treatment target in ALS.